A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A61K 31/192 (2006.01) A61K 31/203 (2006.01) A61K 31/35 (2006.01) A61K 31/351 (2006.01) A61K 31/4433 (2006.01) A61K 31/455 (2006.01)
Patent
CA 2215731
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering a retinoid, such as an RAR-selective retinoid, e.g. the compound of formula (V).
L'invention concerne un procédé visant à prévenir ou réduire le risque de resténose après angioplastie et consistant à administrer un rétinoïde tel qu'un rétinoïde sélectif de RAR, p.ex. le composé de la formule (V).
Benedict Claude R.
Chandraratna Roshantha A.
Davies Peter A. J.
Allergan
Allergan Inc.
Board Of Regents The University Of Texas System
Gowling Lafleur Henderson Llp
LandOfFree
Use of retinoids for the manufacture of a medicament for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of retinoids for the manufacture of a medicament for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of retinoids for the manufacture of a medicament for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1904854